Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cantor Fitzgerald
Julphar
Healthtrust
Harvard Business School
Medtronic
UBS
Covington
Johnson and Johnson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin aspart recombinant

« Back to Dashboard

insulin aspart recombinant

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novo Nordisk Inc NOVOLOG insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986 NDA Novo Nordisk N 0169-3303-12
Novo Nordisk Inc NOVOLOG insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986 NDA Novo Nordisk N 0169-3303-90
Novo Nordisk Inc NOVOLOG insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986 NDA Novo Nordisk N 0169-3303-91
Novo Nordisk Inc NOVOLOG insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986 NDA Novo Nordisk N 0169-6339-10
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chubb
Johnson and Johnson
McKinsey
Healthtrust
Chinese Patent Office
US Army
Julphar
Medtronic